pyrroles has been researched along with Hematochezia in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (5.00) | 29.6817 |
| 2010's | 10 (50.00) | 24.3611 |
| 2020's | 4 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deguchi, H; Fernandez, J; Igarashi, A; Ishii, M; Kawai, T; Suzuki, M; Tsujita, K | 1 |
| D'Haens, G; Dulai, PS; Feagan, BG; Jairath, V; Ma, C; Narula, N; Peyrin-Biroulet, L; Sandborn, WJ; Singh, S; Vande Casteele, N; Vermeire, S | 1 |
| Deguchi, H; Sugano, K; Tsujita, K; Uda, A | 1 |
| Higuchi, K; Hirata, Y; Kakimoto, K; Kinoshita, N; Kojima, Y; Koshiba, R; Miyazaki, T; Nakamura, S; Ota, K; Takeuchi, T; Tanaka, Y; Tawa, H; Tsujimoto, H; Ueda, Y | 1 |
| Fujibayashi, S; Fujiya, M; Goto, T; Kashima, S; Moriichi, K; Nomura, Y; Okumura, T; Sakatani, A; Sasajima, J; Tanaka, K; Ueno, N | 1 |
| Ashida, K; Funao, N; Kawai, T; Mizokami, Y; Nishimura, A; Oda, K; Soen, S; Sugano, K | 1 |
| Ashida, K; Funao, N; Kawai, T; Matsumoto, Y; Mizokami, Y; Nishimura, A; Oda, K; Sugano, K | 1 |
| Dore, MP; Graham, DY | 1 |
| Meng, CX; Takagi, T; Tian, YS; Zhou, Y | 1 |
| Hasui, T; Inaba, T; Ishida, M; Ishikawa, S; Iwamuro, M; Izumikawa, K; Kagawa, T; Kuraoka, S; Matsuura, M; Sakakihara, I; Sasaki, K; Takahashi, S; Tanaka, S; Wato, M; Yamamoto, K | 1 |
| Akamatsu, S; Kanamaru, S; Soeda, A; Takenawa, J | 1 |
| Alikhan, R; Keeling, D | 1 |
| Chang, CC; Chi, KH; Ko, HL; Liao, CS; Mehta, MP; Tsang, YW; Yang, KC | 1 |
| Bories, E; Caillol, F; Giovannini, M; Gravis, G; Jeanniard-Malet, O; Pesenti, C | 1 |
| Guan, F; Ju, J; Li, G; Liu, AB; Sun, Y; Yang, CS; Yang, Z | 1 |
| Joubert, DW | 1 |
| Fernández, E; Rimbau, V; Sabater, J; Torralba, A | 1 |
| Lewis, JR | 1 |
| Beirne, JA; Bianchine, JR; Johnson, PC; Wortham, GF | 1 |
| Allen, JR; Hsu, IC | 1 |
4 trial(s) available for pyrroles and Hematochezia
| Article | Year |
|---|---|
Effect of a proton-pump inhibitor on intestinal microbiota in patients taking low-dose aspirin.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Comorbidity; Dose-Response Relationship, Drug; Esomeprazole; Female; Gastrins; Gastrointestinal Hemorrhage; Gastrointestinal Microbiome; Hematocrit; Hemoglobins; Humans; Intestinal Mucosa; Lactobacillales; Male; Middle Aged; Polymorphism, Restriction Fragment Length; Prospective Studies; Proton Pump Inhibitors; Pyrroles; Sulfonamides | 2021 |
Vonoprazan prevents ulcer recurrence during long-term NSAID therapy: randomised, lansoprazole-controlled non-inferiority and single-blind extension study.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Double-Blind Method; Equivalence Trials as Topic; Female; Gastrointestinal Hemorrhage; Humans; Lansoprazole; Male; Middle Aged; Peptic Ulcer; Pyrroles; Recurrence; Secondary Prevention; Single-Blind Method; Sulfonamides; Survival Analysis; Treatment Outcome | 2018 |
Vonoprazan prevents low-dose aspirin-associated ulcer recurrence: randomised phase 3 study.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Double-Blind Method; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Japan; Lansoprazole; Male; Middle Aged; Peptic Ulcer; Pyrroles; Recurrence; Secondary Prevention; Sulfonamides; Treatment Outcome | 2018 |
Vonoprazan prevents bleeding from endoscopic submucosal dissection-induced gastric ulcers.
Topics: Adenoma; Aged; Aged, 80 and over; Endoscopic Mucosal Resection; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Postoperative Complications; Proton Pump Inhibitors; Pyrroles; Rabeprazole; Stomach Neoplasms; Stomach Ulcer; Sulfonamides; Wound Healing | 2016 |
16 other study(ies) available for pyrroles and Hematochezia
| Article | Year |
|---|---|
Cost-Effectiveness of Vonoprazan Compared With Proton Pump Inhibitors in Patients Taking Low-Dose Aspirin for Secondary Prevention of Cardiovascular Events in Japan.
Topics: Aged; Aspirin; Cardiovascular Diseases; Cost-Benefit Analysis; Esomeprazole; Gastrointestinal Hemorrhage; Humans; Japan; Lansoprazole; Proton Pump Inhibitors; Pyrroles; Secondary Prevention | 2023 |
Prevalence of endoscopic improvement and remission according to patient-reported outcomes in ulcerative colitis.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Clinical Trials as Topic; Cohort Studies; Colitis, Ulcerative; Endoscopy, Gastrointestinal; Female; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Humans; Induction Chemotherapy; Infliximab; Maintenance Chemotherapy; Male; Middle Aged; Patient Reported Outcome Measures; Piperidines; Prevalence; Pyrimidines; Pyrroles; Remission Induction; Young Adult | 2020 |
Upper gastrointestinal bleeding in Japanese patients with ischemic heart disease receiving vonoprazan or a proton pump inhibitor with multiple antithrombotic agents: A nationwide database study.
Topics: Aged; Asian People; Databases, Factual; Female; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Humans; Japan; Male; Myocardial Ischemia; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; Sulfonamides | 2020 |
Second-line therapy for Helicobacter pylori eradication causing antibiotic-associated hemorrhagic colitis.
Topics: Abdominal Pain; Aged; Amoxicillin; Biopsy; Colitis; Colon; Colonoscopy; Female; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Hemorrhage; Humans; Klebsiella oxytoca; Metronidazole; Mucous Membrane; Pyrroles; Rare Diseases; Sulfonamides | 2017 |
Update on the Use of Vonoprazan: A Competitive Acid Blocker.
Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Gastric Acid; Gastric Mucosa; Gastrointestinal Diseases; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Hemostasis, Endoscopic; Humans; Hydrogen-Ion Concentration; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Treatment Outcome | 2018 |
Vonoprazan versus proton pump inhibitors in treating post-endoscopic submucosal dissection ulcers and preventing bleeding: Protocol for meta-analysis of randomized controlled trials and observational studies.
Topics: Endoscopic Mucosal Resection; Epidemiologic Studies; Gastrointestinal Hemorrhage; Humans; Meta-Analysis as Topic; Postoperative Complications; Proton Pump Inhibitors; Pyrroles; Randomized Controlled Trials as Topic; Research Design; Stomach Neoplasms; Stomach Ulcer; Sulfonamides; Systematic Review as Topic; Time Factors | 2019 |
Severe gastrointestinal hemorrhage due to metastatic renal cell carcinoma to the pancreas successfully controlled by transarterial embolization and adjuvant administration of Sunitinib Malate.
Topics: Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Chemotherapy, Adjuvant; Embolization, Therapeutic; Gastrointestinal Hemorrhage; Humans; Indoles; Kidney Neoplasms; Male; Pancreatic Neoplasms; Pyrroles; Sunitinib | 2008 |
Von Willebrand disease, angiodysplasia and atorvastatin.
Topics: Angiodysplasia; Anticholesteremic Agents; Atorvastatin; Gastrointestinal Hemorrhage; Heptanoic Acids; Humans; Male; Middle Aged; Pyrroles; von Willebrand Diseases | 2010 |
Angiogenic blockade and radiotherapy in hepatocellular carcinoma.
Topics: Adult; Aged; alpha-Fetoproteins; Analysis of Variance; Angiogenesis Inhibitors; Antineoplastic Agents; Carcinoma, Hepatocellular; Combined Modality Therapy; Dose Fractionation, Radiation; Female; Gastrointestinal Hemorrhage; Humans; Indoles; Liver Neoplasms; Male; Middle Aged; Pyrroles; Radiotherapy, Intensity-Modulated; Retrospective Studies; Sunitinib; Survival Analysis; Treatment Outcome | 2010 |
Three cases of severe ulcerative esophagitis induced by SUTENT®.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Esophagitis; Gastrointestinal Hemorrhage; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Prostatic Neoplasms; Pyrroles; Sunitinib; Ulcer | 2012 |
Deleterious effects of high concentrations of (-)-epigallocatechin-3-gallate and atorvastatin in mice with colon inflammation.
Topics: Animals; Atorvastatin; Azoxymethane; Catechin; Colitis; Colon; Colonic Neoplasms; Dextran Sulfate; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Gastrointestinal Hemorrhage; Heptanoic Acids; Leukotriene B4; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Pyrroles; Rectum; Weight Loss | 2012 |
Zomepirac overdose and review of literature on acute toxicity of nonsteroidal antiinflammatory agents.
Topics: Adult; Anti-Inflammatory Agents; Arrhythmias, Cardiac; Bicarbonates; Charcoal; Gastrointestinal Hemorrhage; Humans; Ipecac; Kidney Function Tests; Male; Pyrroles; Tolmetin | 1982 |
Comparative study of the gastrointestinal tolerability of tolmetin and 4'-acetamidophenyl-2-(5'-p-toluyl-1'-methylpyrrole) acetate (AU-8001).
Topics: Animals; Feces; Gastrointestinal Diseases; Gastrointestinal Hemorrhage; Hemoglobins; Kinetics; Male; Pyrroles; Rats; Rats, Inbred Strains; Tolmetin | 1983 |
New antirheumatic agents: Fenoprofen calcium (Nalfon), naproxen (Naprosyn), and tolmetin sodium (Tolectin).
Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Aspirin; Fenoprofen; Gastrointestinal Hemorrhage; Humans; Naphthaleneacetic Acids; Naproxen; Osteoarthritis; Phenylpropionates; Pyrroles; Rheumatic Diseases; Spondylitis, Ankylosing; Tolmetin | 1977 |
Gastrointestinal blood loss caused by tolmetin, aspirin, and indomethacin.
Topics: Adult; Anti-Inflammatory Agents; Aspirin; Benzoates; Chromium Radioisotopes; Diet; Female; Gastrointestinal Hemorrhage; Humans; Indomethacin; Male; Melena; Pyrroles; Time Factors | 1974 |
Antimitotic effects of dehydroretronecine pyrrole.
Topics: Animals; Blood Proteins; Body Weight; Diarrhea; Gastric Mucosa; Gastrointestinal Hemorrhage; Hemoglobins; Leukocyte Count; Male; Methanol; Mitosis; Pyrroles; Pyrrolizidine Alkaloids; Rats; Remission, Spontaneous; Serum Albumin; Serum Globulins; Spleen; Stomach Ulcer; Thymus Gland | 1974 |